
Axel Hauschild, MD, University Hospital Schleswig-Holstein
Advertisement
Articles by Axel Hauschild, MD, University Hospital Schleswig-Holstein
Advertisement
Latest Updated Articles
Ipilimumab Dosing Significance in Adjuvant SettingOctober 12th 2020
Immune Checkpoint Inhibition in Stage IV MelanomaOctober 12th 2020
Triple Therapy for the Management of MelanomaOctober 12th 2020
COMBI-AD Trial 5-Year Analysis DataOctober 12th 2020
COMBI-i Trial Data UpdatesOctober 12th 2020
Checkpoint Blockade Trial Data UpdatesOctober 12th 2020
Advertisement
Advertisement
Trending on OncLive
1
Daraxonrasib Plus Gemcitabine/Nab-Paclitaxel Generates Durable Responses in First-Line Metastatic PDAC
2
TroFuse-015 Meets Primary OS End Point With Sac-TMT in Third-Line or Later Gastroesophageal Adenocarcinoma
3
Dr Iyengar on Oral SERD Implementation in Early-Stage HR+ Breast Cancer
4
Dr Gutierrez on Considerations for Investigating SAR445877 in MSS CRC
5







